TP53 and acute myeloid leukemia: The TP53 mutation and no CR was an independent poor prognostic factor for OS both in the whole and non-M3 AML cohorts (P = 0.005 and 0.011 for TP53 mutation, P = 0.000 and 0.001 for CR, respectively).